World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 4 September 2023
Main ID:  NCT03328338
Date of registration: 28/10/2017
Prospective Registration: Yes
Primary sponsor: University Hospital Center of Martinique
Public title: Mitochondrial Function in Transthyretin Amyloidosis MIT-Amylose
Scientific title: Mitochondrial Function in Transthyretin Amyloidosis : the MIT-AMYLOSE Study.
Date of first enrolment: July 17, 2018
Target sample size: 12
Recruitment status: Terminated
URL:  https://clinicaltrials.gov/ct2/show/NCT03328338
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
Martinique
Contacts
Name:     Jocelyn INAMO, MD-PhD
Address: 
Telephone:
Email:
Affiliation:  CHU de Martinique
Key inclusion & exclusion criteria

Inclusion Criteria:

- Have a parietal thickness measuring more than 15 mm on the echocardiography or have
structural and echogenicity abnormalities characteristic of cardiac amyloidosis,

- Live in Martinique,

- Accept the use of the residues coming from biopsies of the subcutaneous abdominal
adipose tissue performed during the medical care.

Exclusion Criteria:

- Be under 18 years old,

- Have a contraindication to subcutaneous biopsy,

- Be allergic to local anesthetics,

- Pregnant or nursing woman,

- Have a cardiovascular disease suggesting a secondary cardiac disease, such as
documented severe hypertension, valvular stenosis, or a known familial cardiomyopathy,

- Be major under guardianship / curatorship or deprived of liberty,

- Not be able to answer to a simple administrative questionnaire or to give freely its
non-opposition.



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Cardiac Amyloidosis
Intervention(s)
Primary Outcome(s)
Oxygen consumption measure in subcutaneous abdominal fat biopsies [Time Frame: Three months]
Secondary Outcome(s)
Rates of oxygen consumption [Time Frame: Three months]
Secondary ID(s)
16/E/17
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history